Chile vs Iraq: Cause of death, by non-communicable diseases, ages 15-59, female
Chile
66.3%
in 2021
Iraq
65.5%
in 2021
Chile rank
75th
Iraq rank
77th
Cause of death, by non-communicable diseases, ages 15-59, female over time
- Chile
- Iraq
How they compare
Chile currently reports 66.3% against 65.5% in Iraq, a difference of 0.8%.
Across all 6 years both countries report, Chile has been ahead every year.
Chile ranks 75th and Iraq ranks 77th of 185 countries.
Chile has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Chile | Iraq | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 81.1% | 64.7% | 16.5% | Chile |
| 2010s | 81.5% | 64.2% | 17.3% | Chile |
| 2020s | 69.7% | 62.6% | 7.0% | Chile |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, female, Chile or Iraq?
- Chile, at 66.3% against 65.5% in Iraq as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59, female between Chile and Iraq?
- 0.8%, with Chile ahead.
- How many years of comparable data are there for Chile and Iraq?
- 6 years are reported by both, from 2000 to 2021.
- How do Chile and Iraq rank globally for cause of death, by non-communicable diseases, ages 15-59, female?
- Chile ranks 75th and Iraq ranks 77th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59, female (% of total female deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 15-59 due to non-communicable diseases divided by number of all female deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.